← All organizations

Massachusetts Eye and Ear Infirmary

Academic/Hospital

Also known as: Faisal Karmali | Faisal_Karmali@MEEI.HARVARD.EDU | Joseph B. Ciolino, MD

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Jan 31, 2022

Timeline

No events for the selected filters.

Drugs by trial phase (3 distinct, 3 trials)

Phase 4 (1 own, 0 via acquisition)

promethazine hydrochloride

Phase 1 (1 own, 0 via acquisition)

riboflavin

Other trials (1 own, 0 via acquisition)

sodium oxybate

Indications

Studied for

Recent trials (3)

NCT04584125Lead sponsorEarly Phase 1Jan 31, 2022
NCT02136420Lead sponsorPhase 4Jun 1, 2014
NCT01961297Lead sponsorN/AJul 1, 2012

Details

Last known activity: Jan 31, 2022